(ALS, Charcot, Lou Gehrig)
Drug-resistant MS spasticity treatment with Sativex® add-on and driving ability
Main results: Treatment of MS patients with Sativex(®) does not negatively impact on driving ability and may improve moderate to ...
Read more…
Read more…
Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review
Main results: In general, cognitive performance declined mostly in a THC dose-dependent manner, with steady resolution of impairment in the ...
Read more…
Read more…
Cannabinoid concentrations in confiscated cannabis samples and in whole blood and urine after smoking CBD-rich cannabis as a tobacco substitute
Main results: All urine samples tested negative by three immunochemical assays for detection of cannabis use. This is an important ...
Read more…
Read more…
Impact of smoking cannabidiol (CBD)-rich marijuana on driving ability
Main results: No significant impact on driving ability was found after smoking CBD-rich marijuana. No effects on vital signs were ...
Read more…
Read more…
Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
Main results: Cannabis containing equivalent concentrations of CBD and THC appears no less impairing than THC-dominant cannabis, and in some ...
Read more…
Read more…
Orally administered cannabidiol (CBD) does not produce false‐positive tests for THC on the Securetec DrugWipe® 5S or Dräger Drug Test® 5000
Main results: Orally administered CBD does not appear to produce false-positive (or true-positive) tests for THC on the DW-5S and ...
Read more…
Read more…
Simulated driving performance among daily and occasional cannabis users
Main results: Occasional users had a similar drug effect as daily users but lower blood THC. Smoked cannabis led to ...
Read more…
Read more…
Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review
Main results: Most driving-related skills are predicted to recover within ∼5-hs (and almost all within ∼7-hs) of inhaling 20 mg Δ9-THC ...
Read more…
Read more…
Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders
Main results: we highlight the possibility that, in addition to neurons, glial changes could help to explain the complex pharmacology ...
Read more…
Read more…
Diversity of molecular targets and signaling pathways for CBD
Main results: CBD’s potential as a therapeutic comes from its multiple mechanisms of action. This wide range of pharmacological activity ...
Read more…
Read more…
